Abstract: A radioactive catalyst is disclosed which comprises a fine particle of semiconductor and a high radioactive platinum group element deposited on the particle of semiconductor. The radioactive catalyst serves as a source of radiation and also as a catalyst for oxidation-reduction reaction. By bringing the radioactive catalyst into contact with water, the water is decomposed by the oxidation-reduction reaction to produce hydrogen and oxygen.

Abstract: Benzalkonium chloride and benzethonium chloride are each useful in radiopharmaceutical preparations as bacteriostatic agents which are compatible with anti-oxidants.

Abstract: A ferric hydroxide colloid having an alpha-emitting radionuclide essentially on the outer surfaces and a method of forming same. The method includes oxidizing a ferrous hydroxide to ferric hydroxide in the presence of a preselected radionuclide to form a colloid having the radionuclide on the outer surface thereof, and thereafter washing the colloid, and suspending the washed colloid in a suitable solution. The labelled colloid is useful in cancer therapy and for the treatment of inflamed joints.

Abstract: Particle emitting radionuclides, e.g. X-90, have been complexed with certain macrocyclic aminophosphonic acids wherein the nitrogen and phosphorus are interconnected by an alkylene group or substituted alkylene group. These complexes have been found useful in compositions and formulations for the therapeutic treatment of calcific tumors and the relief of bone pain in animals.

Abstract: An aggregate suspension containing holmium-166 hydroxide and a carrier (such as a particulate ferric hydroxide) is injected into a patient's anesthetized joint (such as a knee joint or hip joint) for the treatment of inflamed synovial tissues such as present in arthritis, especially rheumatoid arthritis. The aggregate suspension is in a range of particle sizes from 1 to 40 microns. The holmium-166-containing suspension treats the synovial tissues, whereby radiation synovectomy takes place.

Abstract: A ferric hydroxide colloid having an alpha-emitting radionuclide essentially on the outer surfaces and a method of forming same. The method includes oxidizing a ferrous hydroxide to ferric hydroxide in the presence of a preselected radionuclide to form a colloid having the radionuclide on the outer surface thereof, and thereafter washing the colloid, and suspending the washed colloid in a suitable solution. The labelled colloid is useful in cancer therapy and for the treatment of inflamed joints.

Abstract: The disclosed invention consists of a ceramic form of fuel for a nuclear reactor comprising an oxide of a fissionable element and containing therein a consumable neutron absorbing agent. The ceramic fissionable fuel product provides longer fuel performance in nuclear reactor service.

Abstract: The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from the group consisting of Samarium-153, Gadolinium-159, Holmium-166 and Yttrium-90 and at least one macrocyclic aminophosphonic acid ligand containing the 1,4,7,10-tetraazacyclododecane moiety, or a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.

Abstract: An ion exchange material comprises an oxide of a first element selected from elements of Groups IVa, IVb, Va, Vb, VIa, VIb, VIIa, or lanthanide or actinide series of the Periodic Table, in combination with an oxide of at least one different element selected from elements of the afore-mentioned groups of the Periodic Table so as to form a composite material. For example, a composite ion exchange material may comprise silicon dioxide and manganese dioxide. By selecting the appropriate oxides a composite ion exchange material can be prepared which has greater mechanical and/or chemical stability than an individual oxide of the composite material.

Abstract: Ion exchange performed by contacting a solution containing ions to be absorbed with a hydrous oxide of uranium in a suitable form. The hydrous oxide may be uranium dioxide or uranium hydroxide, and may be prepared by reducing a uranium species, precipitating the reduced species, and drying the precipitate to give the required hydrous oxide.

Abstract: Thorium and rare earth values are separated from a fluoride concentrate thereof, by decomposing such concentrate with aqueous sodium hydroxide under conditions such that the amount of sodium hydroxide is at least 1.4 times the stoichiometric amount and the initial sodium hydroxide/water ratio in the medium of decomposition ranges from 1 to 40% by weight, whereby a precipitate of thorium hydroxide and rare earth hydroxides is produced, together with a solution of sodium fluoride, and then separating the NaF solution therefrom.

Abstract: A high melting metal silicide sputtering target which comprises a fine texture whose stoichiometric composition grains of MSi.sub.2, where M represents a high melting metal, have a maximum grain size of 20 .mu.m, whose free silicon grains have a maximum grain size of 50 .mu.m and whose oxygen content is not more than 200 ppm and has a density ratio to the theoretical density of 99% or more has good film characteristics including the reduction in the number of grains formed on the sputtered film and is useful as an electrode material or a wiring material in semi-conductor devices.

Abstract: A formulation is provided for the treatment of synovial inflammation, the formulation consisting of dysprosium-165 hydroxide macroaggregates or yttrium-90 hydroxide macroaggregates, wherein the formulation is substantially devoid of other co-precipitating agents in particular, ferric hydroxide. A method of treatment of synovial inflammation is also provided in which the method comprises adminstering an intra-articular injection of the above formulation. Preferably the above formulation is in the form of a isotonic apyrogenic injectable solution.

Abstract: Radioactive microspheres for radiation synovectomy of arithmetic joints in a mammal comprise a biodegradable glass material and a beta radiation emitting radioisotope chemically dissolved in and distributed substantially uniformly throughout the glass material. The biodegradable glass material may be lithium silicate, lithium aluminosilicate, lithium aluminoborate, lithium germanate, lithium aluminogermanate, potassium silicate, potassium aluminosilicate, potassium, aluminoborate, potassium germanate or potassium aluminogermanate and the beta radiation emitting radioisotope may be samarium-153, holmium-166, erbium-169, dysprosium-165, rhenium-186, rhenium-188 or yttrium-90. Methods for preparing such microspheres and for carrying out radiation synovectomy of arthritic joints utilizing such microspheres are also disclosed.

Abstract: A diagnostic aid for the scintigraphic visualization of malignant tumors which contains a radionuclide which is bonded by means of a complex-forming agent to the substance obtained by the enzymatic processing of murein with enzyme consisting essentially of hen's eggwhite lysozyme.

Abstract: The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from the group consisting of Samarium-153, Gadolinium-159, and Holmium-166 and 1,4,7,10-tetraazacyclododecanetetramethylenephosphonic acid a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.

Abstract: A partitioning radioactive tracer material is prepared by reacting an alkali-metal salt of radioactive iodine with chloroethanol in the presence of activated carbon.

Abstract: A fugitive binder composition for compression molding uranium dioxide nuclear fuel comprising the reaction product of a strongly alkali water solution of a diamine and oxalate ions with uranium oxide which is free of carbonates and carbamates, and having the formula:[.sup.+ NH.sub.3 (CH.sub.2).sub.2 NH.sub.3.sup.+ ][UO.sub.2 (C.sub.2 O.sub.4).sub.2 (H.sub.2 O).sub.2 ][.sup.+ NH.sub.3 (CH.sub.2).sub.2 NH.sub.3.sup.+ ].

Abstract: A radioactive microsphere for radiation therapy of a mammal comprising a biologically compatible glass material containing a beta or gamma emitting radioisotope distributed substantially uniformly throughout the glass. Advantageously, the radioisotope is produced by irradiation of the microsphere.

Abstract: The invention relates to a process for the extraction of uranium (VI) and/or plutonium (IV) present in an aqueous solution by means of N,N-dialkylamides.These N,N-dialkylamides are in accordance with formula: ##STR1## in which R.sup.1 is a straight or branched alkyl radical with 2 to 12 carbon atoms, R.sup.2 and R.sup.4, which can be the same or different, are straight or branched alkyl radicals with 2 to 6 carbon atoms, R.sup.3 and R.sup.5, which can be the same or different, are straight or branched alkyl radicals with 1 to 6 carbon atoms and a and b, which can be the same or different, are integers between 1 and 6.For example, it is possible to use N,N-di-(2-ethyl hexyl)-2,2-dimethyl butyramide, N,N-di-(2-ethyl hexyl)-hexanamide or N,N-di-(2-ethyl hexyl)-dodecanamide for simultaneously extracting uranium and plutonium, or for separating the uranium from the plutonium without reducing the latter.

Abstract: The present invention relates to a process for the heat treatment of uranium alloy members.This process comprises at least one .gamma.-phase homogenization stage, followed by an induction heating stage and a hardening stage. The use of induction heating makes it possible to only heat the member and therefore modify the structure thereof at the surface. Thus, the hardness in the core and on the surface can optionally be adjusted by supplementary hardening and/or tempering stages.Application to the production of protective materials.

Abstract: A new group of materials comprises intercalates of organometallic compounds in layered structures of water-insoluble salts comprised of a tetravalent metal cation and an acid phosphate, arsenate or vanadate anion. Related materials comprise intercalates of organometallic compounds in layered structures of uranyl and transuranyl phosphates, arsenates and vanadates. Intercalation hosts are represented either by the formula M(H.sub.1-y A.sub.y XO.sub.4).sub.2.nH.sub.2 O or by the formula H.sub.1-y A.sub.y TO.sub.2 XO.sub.4.nH.sub.

Abstract: The method of feeding an insoluble organic solid material in the form of an organic resin or biological matter containing contaminating material such as radioactive waste from a nuclear facility or from treatment of animal or plant tissue in a laboratory or medical facility into a vessel containing water and to which ultraviolet light and ozone, preferably by sparging, are applied while the water is being agitated to distribute the ozone. The ozone oxidizes the organic resin or biological material, which disintegrates on oxidation substantially into water and carbon dioxide, leaving substantially no resin or biological material after treatment by the ultraviolet light and ozone for a prescribed period of time, and leaving the contaminant material as a precipitate or in solution in the remaining water or as an escaping gas, in any of which forms it can be readily separated from the water for disposal or further treatment.

Abstract: The invention relates to a process for the automatic preparation of solutions from environmentally noxious substances in solvents whereby the noxious substance is brought on a receiver and by means of an airtight adapter and a feed connection into a hermetical sealed, storage bin, an exact quantity of the substance is dosed into a measuring and mixing vessel by means of a dosing screw after the solvent is dosed into this vessel, the substance is mixed and dissolved maintained at a certain temperature filtered and delivered to a storage vessel in an automatic sequence.

Abstract: Alkali-resistant glass fibres, in the form of continuous-filament for use as reinforcement in cementitious products, or in the form of glass wool, are given enhanced alkali resistance by the incorporation of ThO.sub.2. The fibres are formed from a glass composition comprising, in weight percentages:______________________________________ SiO.sub.2 50 to 75% ThO.sub.2 + ZrO.sub.2 5 to 30% with ThO.sub.2 at least 0.4% R.sub.2 O 0 to 25% R'O 0 to 40% R.sub.2 O + R'O 10 to 40% Rare earth oxides 0 to 20% ______________________________________the content of ThO.sub.2 being at least 1% when the content of ZrO.sub.2 is less than 6% but not exceeding 9.5% when ZrO.sub.2 exceeds 8%, where R.sub.2 O represents Na.sub.2 O, K.sub.2 O or LiO.sub.2, with K.sub.2 O not exceeding 10% and Li.sub.2 O not exceeding 5% and R'O represents one or more of MgO, CaO, SrO, BaO, ZnO and MnO.